06090365 is referenced by 75 patents and cites 16 patents.

Methods for the treatment of lymphoma by administration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.

Title
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
Application Number
121582
Publication Number
6090365
Application Date
November 18, 1997
Publication Date
July 18, 2000
Inventor
Richard L Wahl
Ann Arbor
MI, US
Stephan D Glenn
Davie
FL, US
Gregory M Butchko
Miami Lakes
FL, US
Mark S Kaminski
Ann Arbor
MI, US
Agent
Cooley Godward
Assignee
Regents of the University of Michigan
MI, US
Coulter Pharmaceutical
CA, US
IPC
A01N 33/20
View Original Source